Date Field | Doc. No. | Description (Pages) |
---|
Apr 23, 2021 | 0 | C.R. BARD, INC. v. ANGIODYNAMICS, INCORPORATED [OPINION] [nonprecedential] (0) |
Nov 5, 2018 | 85 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [562687] [17-1851, 17-1865, 17-1906, 17-1931, 17-1943] [PBC] [Entered: 11/05/2018 04:04 PM] (0) |
Sep 28, 2018 | 84 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed in part, Vacated in part, Reversed in part, and Remanded in case nos. 17-1851, 17-1906, and 17-1931. Affirmed in part, Vacated in part, and Remanded in case nos. 17-1943 and 17-1865. (Nonprecedential Opinion). (For the Court: O'Malley, Circuit Judge; Taranto, Circuit Judge and Stoll, Circuit Judge). [553181] [17-1851, 17-1865, 17-1906, 17-1931, 17-1943] [JAB] [Entered: 09/28/2018 09:45 AM] (0) |
Sep 5, 2018 | 83 | Submitted after ORAL ARGUMENT by Mr. Vincent Joseph Belusko for C.R. Bard, Inc. and Bard Peripheral Vascular, Inc. and Ms. Danielle Vincenti Tully, Esq. for Angiodynamics, Incorporated. Panel: Judge: O'Malley , Judge: Taranto , Judge: Stoll. [547286] [JCP] [Entered: 09/05/2018 11:31 AM] (0) |
Aug 15, 2018 | 82 | Response to oral argument order from the Cross-Appellant Angiodynamics, Incorporated. Designating Danielle V. Tully to argue.. Designating 12 minutes for argument. Reserving 3 minutes for rebuttal. [17-1851] [Danielle Tully] [Entered: 08/15/2018 10:08 AM] (0) |
Aug 14, 2018 | 81 | Response to oral argument order from the Appellants C.R. Bard, Inc. and Bard Peripheral Vascular, Inc.. Designating Vincent J. Belusko to argue.. Designating 10 minutes for argument. Reserving 5 minutes for rebuttal. [17-1851] [Vincent Belusko] [Entered: 08/14/2018 11:38 AM] (0) |
Aug 9, 2018 | 80 | RESPONSE of Appellants C.R. Bard, Inc. and Bard Peripheral Vascular, Inc. to the supplemental authority [79] filed by Cross-Appellant Angiodynamics, Incorporated. Service: 08/09/2018 by email. [541841] [17-1851] [Vincent Belusko] [Entered: 08/09/2018 03:44 PM] (0) |
Aug 2, 2018 | 79 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Cross-Appellant Angiodynamics, Incorporated. Service: 08/02/2018 by email. [540538] [17-1851] [Danielle Tully] [Entered: 08/02/2018 05:29 PM] (0) |
Jul 20, 2018 | 78 | NOTICE OF CALENDARING. Panel: 1809F. Case scheduled Sep 05, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to oral argument order due: 08/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [537295] [JAB] [Entered: 07/20/2018 12:12 PM] (0) |
Jun 15, 2018 | 77 | RESPONSE of Appellants C.R. Bard, Inc. and Bard Peripheral Vascular, Inc. to the supplemental authority [76] filed by Cross-Appellant Angiodynamics, Incorporated. Service: 06/15/2018 by email. [530051] [17-1851] [Vincent Belusko] [Entered: 06/15/2018 06:00 PM] (0) |
May 30, 2018 | 76 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Cross-Appellant Angiodynamics, Incorporated. Service: 05/30/2018 by email. [525635] [17-1851] [Danielle Tully] [Entered: 05/30/2018 06:00 PM] (0) |
Mar 20, 2018 | 75 | 6 paper copies of the Joint Appendix in 3 Volumes [69] received from Appellants Bard Peripheral Vascular, Inc. and C.R. Bard, Inc. [507017] [JCP] [Entered: 03/22/2018 08:11 AM] (0) |
Mar 20, 2018 | 74 | Notice from Cross-Appellant Angiodynamics, Incorporated regarding conflicts with oral argument (Re: Unavailability for Oral Argument). Service: 03/20/2018 by email. [506755] [17-1851] [Danielle Tully] [Entered: 03/20/2018 03:57 PM] (2) |
Mar 20, 2018 | 73 | NOTICE OF DEFICIENCY: The party letter Document No. [72] filed by Cross-Appellant Angiodynamics, Incorporated in 17-1851 is submitted using the incorrect event and therefore cannot be accepted for filing at this time (Document must be refiled under the "Notice Regarding Conflicts with Argument Dates" event). You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [506746] [JAB] [Entered: 03/20/2018 03:43 PM] (0) |
Mar 20, 2018 | 72 | Letter from Cross-Appellant Angiodynamics, Incorporated Re: Unavailability for Oral Arguemnt. Service: 03/20/2018 by email. [506710] [17-1851] [Danielle Tully] [Entered: 03/20/2018 02:50 PM] (0) |
Mar 20, 2018 | 71 | Notice from Appellant C.R. Bard, Inc. regarding conflicts with oral argument (April 30 - May 4, 2018; July & August 2018 court sessions.). Service: 03/20/2018 by email. [506688] [17-1851] [Vincent Belusko] [Entered: 03/20/2018 02:20 PM] (2) |
Mar 13, 2018 | 70 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [May, June, July], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 03/20/2018. [504535] [CMP] [Entered: 03/13/2018 11:08 AM] (0) |
Mar 12, 2018 | 69 | APPENDIX FILED for Bard Peripheral Vascular, Inc. and C.R. Bard, Inc. [68]. Number of Pages: 1231. Service: 03/12/2018 by email. The paper copies of the brief should be received by the court on or before 03/21/2018. [504530] [CMP] [Entered: 03/13/2018 11:06 AM] (1231) |
Mar 12, 2018 | 68 | TENDERED from Appellant C.R. Bard, Inc.. Title: JOINT APPENDIX. Service: 03/12/2018 by email. [504383] [Vincent Belusko] [Entered: 03/12/2018 05:27 PM] (1231) |
Mar 7, 2018 | 67 | 6 paper copies of the Reply Brief [66] received from Cross-Appellant Angiodynamics, Incorporated. [503191] [JCP] [Entered: 03/07/2018 12:16 PM] (0) |
Mar 5, 2018 | 66 | REPLY BRIEF FILED for Cross-Appellant Angiodynamics, Incorporated [65]. Number of Pages: 32. Service: 03/05/2018 by email. The paper copies of the brief should be received by the court on or before 03/13/2018. Appendix is due 03/12/2018. [502851] [CMP] [Entered: 03/06/2018 12:52 PM] (41) |
Mar 5, 2018 | 65 | TENDERED from Cross-Appellant Angiodynamics, Incorporated. Title: REPLY BRIEF. Service: 03/05/2018 by email. [502729] [Danielle Tully] [Entered: 03/05/2018 09:33 PM] (41) |
Jan 25, 2018 | 64 | **TEXT ONLY** ORDER granting motion to extend time to file cross-appellant's reply brief [63] filed by Cross-Appellant Angiodynamics, Incorporated. Cross-Appellant's reply brief is due 03/05/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [492818] [CMP] [Entered: 01/25/2018 03:47 PM] (0) |
Jan 23, 2018 | 63 | MOTION of Cross-Appellant Angiodynamics, Incorporated to extend the time to 03/05/2018 to file the cross-appellant's reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 01/23/2018 by email. [492098] [Danielle Tully] [Entered: 01/23/2018 05:07 PM] (8) |
Jan 23, 2018 | 62 | 6 paper copies of the Reply Brief [61] received from Appellants Bard Peripheral Vascular, Inc. and C.R. Bard, Inc. [491934] [CFT] [Entered: 01/23/2018 01:58 PM] (0) |
Jan 19, 2018 | 60 | TENDERED from Appellants Bard Peripheral Vascular, Inc. and C.R. Bard, Inc.. Title: RESPONSE BRIEF. Service: 01/19/2018 by email. [491130] [Vincent Belusko] [Entered: 01/19/2018 05:13 PM] (81) |
Jan 19, 2018 | 61 | REPLY BRIEF FILED for Appellants Bard Peripheral Vascular, Inc. and C.R. Bard, Inc. [60]. Number of Pages: 67. Service: 01/19/2018 by email. The paper copies of the brief should be received by the court on or before 01/29/2018. Cross-Appellant's reply brief is due 02/02/2018. [491236] [CMP] [Entered: 01/22/2018 09:27 AM] (81) |
Dec 7, 2017 | 59 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [58] filed by Appellants C.R. Bard, Inc. and Bard Peripheral Vascular, Inc.. Reply brief is due 01/19/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [480919] [CMP] [Entered: 12/07/2017 12:00 PM] (0) |
Dec 6, 2017 | 58 | MOTION of Appellants Bard Peripheral Vascular, Inc. and C.R. Bard, Inc. to extend the time to 01/18/2018 at 11:59 pm to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/06/2017 by email. [480676] [Vincent Belusko] [Entered: 12/06/2017 02:46 PM] (8) |
Nov 29, 2017 | 57 | 6 paper copies of the Corrected Amicus Brief [53] received from Amicus Curiae Medical Components, Inc. [478944] [CW] [Entered: 11/29/2017 02:18 PM] (0) |
Nov 28, 2017 | 56 | Entry of appearance for Michael J. Sebba as of counsel for Cross-Appellant Angiodynamics, Incorporated. Service: 11/28/2017 by email. [478519] [Michael Sebba] [Entered: 11/28/2017 10:43 AM] (1) |
Nov 22, 2017 | 55 | Certificate of Interest for the Amicus Curiae Medical Components, Inc.. Service: 11/22/2017 by email. [477885] [Alfred Zaher] [Entered: 11/22/2017 02:18 PM] (3) |
Nov 22, 2017 | 54 | Clerk's Note to the File: Certificate of Interest is due 12/06/2017 for Amicus Curiae Medical Components, Inc.. [477865] [CMP] [Entered: 11/22/2017 01:39 PM] (0) |
Nov 22, 2017 | 53 | CORRECTED AMICUS BRIEF FILED for Medical Components, Inc. [52]. Number of Pages: 12. Service: 11/22/2017 by email. The paper copies of the brief should be received by the court on or before 12/01/2017. [477862] [CMP] [Entered: 11/22/2017 01:36 PM] (20) |
Nov 22, 2017 | 52 | TENDERED from Medical Components, Inc. Title: CORRECTED AMICUS CURIAE BRIEF. Service: 11/22/2017 by email. [477824] [Alfred Zaher] [Entered: 11/22/2017 12:17 PM] (20) |
Nov 20, 2017 | 51 | NOTICE OF REJECTION: The brief of Medical Components, Inc., Brief for Amicus Curiae in Support of Cross-Appellant [48], is not in compliance with the rules of this court and is therefore rejected for filing. Service as of this date by Clerk of Court. [476957] [CMP] [Entered: 11/20/2017 12:12 PM] (2) |
Nov 16, 2017 | 50 | Entry of appearance for Ralph G. Fischer as of counsel for Medical Components, Inc.. Service: 11/16/2017 by email. [476280] [Ralph Fischer] [Entered: 11/16/2017 03:19 PM] (2) |
Nov 16, 2017 | 49 | Entry of appearance for Alfred W. Zaher as principal counsel for Medical Components, Inc.. Service: 11/16/2017 by email. [476276] [Alfred Zaher] [Entered: 11/16/2017 03:13 PM] (2) |
Nov 16, 2017 | 48 | TENDERED from Medical Components, Inc. Title: AMICUS CURIAE BRIEF. Service: 11/16/2017 by email. [476272] This brief has been rejected. See Doc No. [51]. [Alfred Zaher] [Entered: 11/16/2017 03:11 PM] (0) |
Nov 14, 2017 | 47 | 6 paper copies of the Opening Response Brief [46] received from Cross-Appellant Angiodynamics, Incorporated. [475395] [CW] [Entered: 11/14/2017 02:35 PM] (0) |
Nov 9, 2017 | 46 | BRIEF FILED for Cross-Appellant Angiodynamics, Incorporated [45]. Number of Pages: 79. Service: 11/09/2017 by email. The paper copies of the brief should be received by the court on or before 11/20/2017. Appellant's reply brief is due 12/19/2017. [474700] [CMP] [Entered: 11/13/2017 10:39 AM] (91) |
Nov 9, 2017 | 45 | TENDERED from Cross-Appellant Angiodynamics, Incorporated. Title: RESPONSE BRIEF. Service: 11/09/2017 by email. [474529] [Danielle Tully] [Entered: 11/09/2017 10:28 PM] (91) |
Nov 9, 2017 | 44 | Certificate of Interest for the Cross-Appellant Angiodynamics, Incorporated. Service: 11/09/2017 by email. [474522] [Danielle Tully] [Entered: 11/09/2017 08:11 PM] (2) |
Oct 11, 2017 | 43 | ORDER filed. The motion [34] is granted to the extent that BPV is joined as an additional appellant in these appeals. The revised official caption is reflected in the order. Service: 10/11/2017 by clerk. [467017] [LMS] [Entered: 10/11/2017 02:48 PM] (2) |
Sep 8, 2017 | 42 | **TEXT ONLY** ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [41] filed by Cross-Appellant Angiodynamics, Incorporated. Cross-Appellant Angiodynamics, Incorporated brief is due 11/09/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [459778] [CMP] [Entered: 09/08/2017 02:00 PM] (0) |
Sep 8, 2017 | 40 | 6 paper copies of the Corrected Opening Brief [38] received from Appellant C.R. Bard, Inc. [459690] [CW] [Entered: 09/08/2017 11:35 AM] (0) |
Sep 8, 2017 | 41 | MOTION of Cross-Appellant Angiodynamics, Incorporated to extend the time to 11/09/2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 09/08/2017 by email. [459722] [Danielle Tully] [Entered: 09/08/2017 01:03 PM] (7) |
Sep 1, 2017 | 39 | RESPONSE of Cross-Appellant Angiodynamics, Incorporated to the motion for other relief [34] filed by Appellant C.R. Bard, Inc. in 17-1851 , motion to substitute party [34] filed by Appellant C.R. Bard, Inc. in 17-1851. Service: 09/01/2017 by email. [458375] [Danielle Tully] [Entered: 09/01/2017 03:45 PM] (6) |
Aug 31, 2017 | 36 | Notice of Correction to the Brief Doc No. [35] for Appellant C.R. Bard, Inc.. Service: 08/31/2017 by email. [458093] [Vincent Belusko] [Entered: 08/31/2017 03:53 PM] (4) |
Aug 31, 2017 | 37 | TENDERED from Appellant C.R. Bard, Inc.. Title: CORRECTED OPENING BRIEF. Service: 08/31/2017 by email. [458102] [Vincent Belusko] [Entered: 08/31/2017 04:10 PM] (391) |
Aug 31, 2017 | 38 | CORRECTED BRIEF FILED for Appellant C.R. Bard, Inc. [37]. Number of Pages: 64. Service: 08/31/2017 by email. The paper copies of the brief should be received by the court on or before 09/11/2017. Cross-Appellant Angiodynamics, Incorporated brief is due 10/10/2017. [458191] [CMP] [Entered: 09/01/2017 09:45 AM] (391) |
Aug 30, 2017 | 35 | TENDERED from Appellant C.R. Bard, Inc.. Title: OPENING BRIEF. Service: 08/30/2017 by email. [457875] [Vincent Belusko] [Entered: 08/30/2017 06:56 PM] (0) |
Aug 22, 2017 | 34 | MOTION of Appellant C.R. Bard, Inc. Join Party. Any response is due within 10 days of service, to substitute party. Any response is due within 10 days of service [Consent: partial consent]. Service: 08/22/2017 by email. [455835] [Vincent Belusko] [Entered: 08/22/2017 02:06 PM] (7) |
Jul 12, 2017 | 33 | **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [32] filed by Appellant C.R. Bard, Inc.. Brief is due 08/30/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [445893] [CMP] [Entered: 07/12/2017 01:19 PM] (0) |
Jul 12, 2017 | 32 | MOTION of Appellant C.R. Bard, Inc. to extend the time to 08/30/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/12/2017 by email. [445795] [Vincent Belusko] [Entered: 07/12/2017 09:34 AM] (7) |
Jul 11, 2017 | 31 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [445470] [CMP] [Entered: 07/11/2017 09:13 AM] (0) |
May 30, 2017 | 30 | Certified list from the United States Patent and Trademark Office. Service: 05/30/2017 by email. Appellant's brief is due 07/31/2017. [434887] [17-1851, 17-1865, 17-1906, 17-1931, 17-1943] [CMP] [Entered: 05/30/2017 12:39 PM] (197) |
Apr 27, 2017 | 29 | Amended Entry of appearance for Danielle V. Tully as principal counsel for Cross-Appellant Angiodynamics, Incorporated. Service: 04/27/2017 by email. [427665] [Danielle Tully] [Entered: 04/27/2017 04:49 PM] (2) |
Apr 27, 2017 | 28 | Amended Entry of appearance for Michael B. Powell as of counsel for Cross-Appellant Angiodynamics, Incorporated. Service: 02/27/2017 by email. [427663] [Michael Powell] [Entered: 04/27/2017 04:46 PM] (2) |
Apr 27, 2017 | 27 | Amended Entry of appearance for John T. Moehringer as of counsel for Cross-Appellant Angiodynamics, Incorporated. Service: 02/27/2017 by email. [427661] [John Moehringer] [Entered: 04/27/2017 04:42 PM] (2) |
Apr 27, 2017 | 26 | Amended Entry of appearance for Christopher A. Hghes as of counsel for Cross-Appellant Angiodynamics, Incorporated. Service: 02/27/2017 by email. [427660] [Christopher Hughes] [Entered: 04/27/2017 04:39 PM] (2) |
Apr 27, 2017 | 25 | Entry of appearance for Danielle V. Tully as principal counsel for Cross-Appellant Angiodynamics, Incorporated. Service: 02/27/2017 by email. [427639] [Danielle Tully] [Entered: 04/27/2017 03:58 PM] (2) |
Apr 27, 2017 | 24 | Notice of Election to participate in appeal pursuant to the provisions of 37 CFR Section 1.983(e) from Cross-Appellant Angiodynamics, Incorporated. Service: 02/21/2017 by email. [427634] [Danielle Tully] [Entered: 04/27/2017 03:56 PM] (4) |
Apr 27, 2017 | 23 | Certificate of Interest for the Cross-Appellant Angiodynamics, Incorporated. Service: 02/27/2017 by email. [427633] [Danielle Tully] [Entered: 04/27/2017 03:55 PM] (2) |
Apr 27, 2017 | 22 | Docketing Statement for the Cross-Appellant Angiodynamics, Incorporated. Service: 04/27/2017 by email. [427631] [Danielle Tully] [Entered: 04/27/2017 03:52 PM] (4) |
Apr 27, 2017 | 21 | Notice of Election to participate in appeal pursuant to the provisions of 37 CFR Section 1.983(e) from Appellant C.R. Bard, Inc.. Service: 04/27/2017 by email. [427466] [Arnold Turk] [Entered: 04/27/2017 10:23 AM] (4) |
Apr 26, 2017 | 19 | ORDER consolidating appeals (17-1851, 17-1865, 17-1906, 17-1931, 17-1943). The revised official caption is reflected in the order. The certified lists are due no later than May 30, 2017. Service as of this date by Clerk of Court. [427265] [17-1851, 17-1865, 17-1906, 17-1931, 17-1943] [CMP] [Entered: 04/26/2017 12:56 PM] (2) |
Apr 26, 2017 | 20 | Note to file: The following cases are associated: 17-1851 Lead with 17-1865 Cross-Appeal, 17-1906 Consolidated, 17-1931 Consolidated, and 17-1943 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [427271] [17-1851, 17-1865, 17-1906, 17-1931, 17-1943] [CMP] [Entered: 04/26/2017 01:03 PM] (0) |
Apr 21, 2017 | 18 | Notice of Election to participate in appeal pursuant to the provisions of 37 CFR Section 1.983(e) from Cross-Appellant Angiodynamics, Incorporated. Service: 04/21/2017 by email. [426159] [Danielle Tully] [Entered: 04/21/2017 12:31 PM] (4) |
Apr 19, 2017 | 17 | Note to file: The following cases are associated:17-1851 Lead with 17-1865 Cross-Appeal, 17-1906 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [425453] [17-1851, 17-1865, 17-1906] [JCA] [Entered: 04/19/2017 11:22 AM] (0) |
Apr 19, 2017 | 16 | ORDER consolidating appeals (17-1851, 17-1865, 17-1906). The appeals are consolidated. The revised official caption is reflected in the order. The certified lists are due no later than May 23, 2017. Service as of this date by Clerk of Court. [425449] [17-1851, 17-1865, 17-1906] [JCA] [Entered: 04/19/2017 11:19 AM] (2) |
Apr 13, 2017 | 15 | Entry of appearance for Seth W. Lloyd as of counsel for Appellant C.R. Bard, Inc.. Service: 04/13/2017 by email. [424012] [Seth Lloyd] [Entered: 04/13/2017 04:45 PM] (2) |
Apr 13, 2017 | 14 | Entry of appearance for Nicole M. Smith as of counsel for Appellant C.R. Bard, Inc.. Service: 04/13/2017 by email. [424011] [Nicole Smith] [Entered: 04/13/2017 04:44 PM] (2) |
Apr 13, 2017 | 13 | Entry of appearance for Brian R. Matsui as of counsel for Appellant C.R. Bard, Inc.. Service: 04/13/2017 by email. [424009] [Brian Matsui] [Entered: 04/13/2017 04:43 PM] (2) |
Apr 13, 2017 | 12 | Docketing Statement for the Appellant C.R. Bard, Inc.. Service: 04/13/2017 by email. [424007] [Vincent Belusko] [Entered: 04/13/2017 04:42 PM] (4) |
Apr 13, 2017 | 11 | Certificate of Interest for the Appellant C.R. Bard, Inc.. Service: 04/13/2017 by email. [424005] [Vincent Belusko] [Entered: 04/13/2017 04:41 PM] (2) |
Apr 13, 2017 | 10 | Entry of appearance for Vincent J. Belusko as principal counsel for Appellant C.R. Bard, Inc.. Service: 04/13/2017 by email. [424003] [Vincent Belusko] [Entered: 04/13/2017 04:40 PM] (2) |
Apr 13, 2017 | 9 | Certificate of Interest for the Cross-Appellant Angiodynamics, Incorporated. Service: 04/13/2017 by email. [423952] [Danielle Tully] [Entered: 04/13/2017 04:02 PM] (3) |
Apr 13, 2017 | 8 | Docketing Statement for the Cross-Appellant Angiodynamics, Incorporated. Service: 04/13/2017 by email. [423948] [Danielle Tully] [Entered: 04/13/2017 04:01 PM] (5) |
Apr 13, 2017 | 7 | Entry of appearance for Michael B. Powell as of counsel for Cross-Appellant Angiodynamics, Incorporated. Service: 04/13/2017 by email. [423939] [Michael Powell] [Entered: 04/13/2017 03:58 PM] (3) |
Apr 13, 2017 | 6 | Entry of appearance for John T. Moehringer as of counsel for Cross-Appellant Angiodynamics, Incorporated. Service: 04/13/2017 by email. [423930] [John Moehringer] [Entered: 04/13/2017 03:54 PM] (3) |
Apr 13, 2017 | 5 | Entry of appearance for Christopher A. Hughes as of counsel for Cross-Appellant Angiodynamics, Incorporated. Service: 04/13/2017 by email. [423920] [Christopher Hughes] [Entered: 04/13/2017 03:49 PM] (3) |
Apr 13, 2017 | 4 | Entry of appearance for Danielle V. Tully as principal counsel for Cross-Appellant Angiodynamics, Incorporated. Service: 04/13/2017 by email. [423903] [Danielle Tully] [Entered: 04/13/2017 03:41 PM] (3) |
Apr 12, 2017 | 3 | Notice of Election to participate in appeal pursuant to the provisions of 37 CFR Section 1.983(e) from Cross-Appellant Angiodynamics, Incorporated. Service: 04/12/2017 by email. [423634] [Danielle Tully] [Entered: 04/12/2017 05:19 PM] (4) |
Apr 3, 2017 | 2 | Note to file: The following cases are associated: 17-1851 Lead with 17-1865 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [420898] [17-1851, 17-1865] [CMP] [Entered: 04/03/2017 12:05 PM] (0) |
Mar 30, 2017 | 1 | Appeal docketed. Received: 03/27/2017. [420173] Entry of Appearance due 04/13/2017. Certificate of Interest is due on 04/13/2017. Docketing Statement due 04/13/2017. Certified List due on 05/09/2017. [CMP] [Entered: 03/30/2017 10:03 AM] (66) |